Abstract:The capacity to collect and analyse data is growing exponentially. Referred to as ‘Big Data’, this scientific, social and technological trend has helped create destabilising amounts of information, which can challenge accepted social and ethical norms. Big Data remains a fuzzy idea, emerging across social, scientific, and business contexts sometimes seemingly related only by the gigantic size of the datasets being considered. As is often the case with the cutting edge of scientific and technological progress, understanding of the ethical implications of Big Data lags behind. In order to bridge such a gap, this article systematically and comprehensively analyses academic literature concerning the ethical implications of Big Data, providing a watershed for future ethical investigations and regulations. Particular attention is paid to biomedical Big Data due to the inherent sensitivity of medical information. By means of a meta-analysis of the literature, a thematic narrative is provided to guide ethicists, data scientists, regulators and other stakeholders through what is already known or hypothesised about the ethical risks of this emerging and innovative phenomenon. Five key areas of concern are identified: (1) informed consent, (2) privacy (including anonymisation and data protection), (3) ownership, (4) epistemology and objectivity, and (5) ‘Big Data Divides’ created between those who have or lack the necessary resources to analyse increasingly large datasets. Critical gaps in the treatment of these themes are identified with suggestions for future research. Six additional areas of concern are then suggested which, although related have not yet attracted extensive debate in the existing literature. It is argued that they will require much closer scrutiny in the immediate future: (6) the dangers of ignoring group-level ethical harms; (7) the importance of epistemology in assessing the ethics of Big Data; (8) the changing nature of fiduciary relationships that become increasingly data saturated; (9) the need to distinguish between ‘academic’ and ‘commercial’ Big Data practices in terms of potential harm to data subjects; (10) future problems with ownership of intellectual property generated from analysis of aggregated datasets; and (11) the difficulty of providing meaningful access rights to individual data subjects that lack necessary resources. Considered together, these eleven themes provide a thorough critical framework to guide ethical assessment and governance of emerging Big Data practices.

Treating medical data as a durable asset

Biomedical Big Data: New Models of Control Over Access, Use and Governance

Enabling responsible public genomics

Privacy in the age of medical big data

Digital phenotyping and sensitive health data: Implications for data governance

Fidelity and Privacy of Synthetic Medical Data

Long-term preservation of biomedical research data

The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts

Patient information ownership in the age of digital health and big data

Big Data, precision medicine and private insurance: A delicate balancing act

Who Owns the Data? Open Data for Healthcare

Beyond the hype of big data and artificial intelligence: building foundations for knowledge and wisdom

The impact of commercial health datasets on medical research and health-care algorithms

Unlocking the potential of big data and AI in medicine: insights from biobanking

Big Data Privacy in Biomedical Research

Functional genomics data: privacy risk assessment and technological mitigation

Future-proofing genomic data and consent management: a comprehensive review of technology innovations

Harnessing the power of synthetic data in healthcare: innovation, application, and privacy

Privacy Policy and Technology in Biomedical Data Science.

Privacy in the digital world: medical and health data outside of HIPAA protections

[Synthetic data in medicine: Generation, evaluation and limits]